6 terminated, 3 withdrawn, 1 recruiting. 10 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 10 | Terminated 6, Withdrawn 3, Recruiting 1 |
Follow AlloRx: new trials by email Literature Review of AlloRx trials Research Report on AlloRx
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cells for Testicular Injury and Oligospermia AlloRx - Testicular Injury, Oligospermia | Phase 1 | Withdrawn | The Foundation for Orthopaedics and Regenerative Medicine | 2025-04-03 | 2025-04-06 | |
| Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cells for Ovarian Failure AlloRx - Ovarian Failure | Phase 1 | Withdrawn | The Foundation for Orthopaedics and Regenerative Medicine | 2025-04-03 | 2025-04-06 | |
| Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cell Intravenous Infusion for Osteoporosis AlloRx - Osteoporosis | Phase 1 | Withdrawn | The Foundation for Orthopaedics and Regenerative Medicine | 2022-12-08 | 2025-04-08 | |
| Safety of Cultured Allogeneic Adult Umbilical Cord or Placental Derived Mesenchymal Stem Cells for OA AlloRx - Osteoarthritis, Spinal Arthritis | Phase 1 | Recruiting | The Foundation for Orthopaedics and Regenerative Medicine | 92 | 2022-12-01 | 2026-10-16 |
| Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cell IV Infusion for Systemic Sclerosis AlloRx - Systemic Sclerosis | Phase 1 | Terminated | The Foundation for Orthopaedics and Regenerative Medicine | 20 | 2022-07-04 | 2026-10-20 |
| Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cell Intravenous Infusion for IPF AlloRx - Idiopathic Pulmonary Fibrosis | Phase 1 | Terminated | The Foundation for Orthopaedics and Regenerative Medicine | 20 | 2022-07-03 | 2026-10-20 |
| Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cells for Heart Disease AlloRx - Congestive Heart Failure, Angina | Phase 1 | Terminated | The Foundation for Orthopaedics and Regenerative Medicine | 3 | 2022-02-01 | 2026-10-20 |
| Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cell Intravenous Infusion for Diabetes AlloRx - Diabetes | Phase 1 | Terminated | The Foundation for Orthopaedics and Regenerative Medicine | 2 | 2021-11-06 | 2026-10-20 |
| Safety of Cultured Allogeneic Adult Umbilical Cord or Placental Derived Mesenchymal Stem Cell Intravenous Infusion for CKD AlloRx - Chronic Kidney Diseases | Phase 1 | Terminated | The Foundation for Orthopaedics and Regenerative Medicine | 20 | 2021-11-06 | 2026-10-20 |
| Safety of Cultured Allogeneic Adult Umbilical Cord Stem Cells for Peyronie's Disease, ED, and Interstitial Cystitis AlloRx - Erectile Dysfunction, Peyronie's Disease | Phase 1 | Terminated | The Foundation for Orthopaedics and Regenerative Medicine | 20 | 2021-09-12 | 2026-10-20 |
Angina Pectoris (1) · Cystitis, Interstitial (1) · Diabetes Mellitus (1) · Erectile Dysfunction (1) · Heart Failure (1) · Idiopathic Pulmonary Fibrosis (1) · Kidney Diseases (1) · Oligospermia (1) · Osteoarthritis (1) · Osteoporosis (1) · Penile Induration (1) · Renal Insufficiency (1) · Renal Insufficiency, Chronic (1) · Scleroderma, Diffuse (1) · Scleroderma, Systemic (1)
The Foundation for Orthopaedics and Regenerative Medicine (10)
Antigua and Barbuda (9) · Argentina (3) · Greece (1) · United States (1)